PharmaCyte Biotech Standard Deviation
| PMCB Stock | | | USD 0.77 0.04 5.48% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is PharmaCyte Biotech's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
PharmaCyte Biotech has a Standard Deviation of 4.6, indicating elevated price variability. This places PharmaCyte Biotech toward the higher end of the volatility range for Stock.
Standard Deviation | = | SQRT(V) |
| = | 4.6 | |
Standard Deviation Peers Comparison
Relative to peers, PharmaCyte Biotech's Standard Deviation is below the group average of 9.65. Peer readings range from 2.87 (Radiopharm Theranostics Limited) to 39.8 (Cyclerion Therapeutics), reflecting wide dispersion across the sector. PharmaCyte Biotech has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for PharmaCyte Biotech and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
PharmaCyte Biotech's Maximum Drawdown of
24.36 runs about
5.29 times its Standard Deviation of
4.60 . This indicates Maximum Drawdown substantially exceeds Standard Deviation for PharmaCyte Biotech.
Methodology, Assumptions & Data Sources
PharmaCyte Biotech's Standard Deviation currently stands at 4.6. Standard Deviation for PharmaCyte Biotech is derived by applying a defined formula to historical price observations, producing a time-series of comparable readings. Data sources include daily closing prices from supported exchanges, with standard corporate action adjustments applied. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators